| abstract |
Inhibitors of HBV replication of Formula (A) n nincluding stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R a to R d , and R 5 to R 6 have the meaning as defined herein.n n The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy. |